Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Profit After Tax (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Profit After Tax for 3 consecutive years, with -$20.8 million as the latest value for Q4 2025.

  • For Q4 2025, Profit After Tax fell 29.06% year-over-year to -$20.8 million; the TTM value through Dec 2025 reached -$83.9 million, down 28.29%, while the annual FY2025 figure was -$83.9 million, 28.29% down from the prior year.
  • Profit After Tax hit -$20.8 million in Q4 2025 for Artiva Biotherapeutics, up from -$21.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $11.3 million in Q3 2023 and bottomed at -$21.5 million in Q3 2025.
  • Average Profit After Tax over 3 years is -$14.7 million, with a median of -$17.5 million recorded in 2024.
  • Year-over-year, Profit After Tax tumbled 254.91% in 2024 and then fell 19.12% in 2025.
  • Artiva Biotherapeutics' Profit After Tax stood at -$12.0 million in 2023, then tumbled by 34.15% to -$16.1 million in 2024, then fell by 29.06% to -$20.8 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$20.8 million, -$21.5 million, and -$21.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.